Stockreport

Kineta to Receive $5 Million Milestone Payment from Merck

Kineta, Inc.  (KA) 
PDF SEATTLE, June 29, 2023 (GLOBE NEWSWIRE) -- (June 29, 2023) Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immuno [Read more]